Special Issue "The Age of In-Silico Methods in Drug Discovery, Development, Manufacture and Quality Control"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 6618
Interests: pharmaceutical analysis; analytical method development and validation; bioanalytical method development and validation; mass spectrometry; chemometrics
It is our pleasure to present a Special Issue of Pharmaceuticals entitled “The Age of In-Silico Methods in Drug Discovery, Development, Manufacture and Quality Control”. Pharmaceuticals are an indispensable part of human life, including vitamins, painkillers and antibiotics. Therefore, a drug product that is manufactured and brought to the market must be safe, effective, and adequately formulated with consistent and predictable performance (i.e., with ensured quality as well as lifesaving and/or life-enhancing action). A great deal of effort, energy, experimentation and time is spent to provide patients and consumers with highly effective drugs of uniform quality. In the era of technological revolution and digitalization, in silico methods can be employed in pharmaceutical research and development to assist, lead and encourage analysts in the field in proper decision making, and in reaching conclusions. This is in line with the aim of Industry 5.0 that places the wellbeing of the worker at the center of the production process and uses new technologies to provide prosperity, research and innovation. Sustainable, human-centric and resilient approaches are highly desirable to aid overloaded analysts in the field.
In light of the above, in this Special Issue we will publish studies concerning the latest scientific news, insights, and advances in the field of in silico methods useful in drug discovery, development, manufacture and quality control. Original research articles, short communications, and critical review articles dealing with proposed topic are welcome. The information presented will certainly arouse considerable interest among a large group of future readers from different disciplines and research fields.
Prof. Dr. Anđelija M. Malenović
Dr. Ana Protić
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- in silico methods
- target identification and validation
- lead optimization
- drug delivery
- formulation optimization and bioavailability
- safety and efficacy
- pharmacokinetic analysis
- pharmaceutical manufacturing process development
- quality control